Pacific Health Care Organization Inc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Pacific Health Care Organization Inc's ROA in the second quarter of 2026?
Pacific Health Care Organization Inc achieved a return on average assets (ROA) of 7.09 % in its second quarter of 2026, which is below Pacific Health Care Organization Inc's average return on assets, which stands at 13.61%.

ROA fell compared to the first quarter of 2026, despite the net income growth of 68.82% from the first quarter of 2026.

However, within the Healthcare sector 113 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 534 to 544.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	7.2 %	10.41 %	10.18 %	9.51 %	11.49 %
Y / Y Net Income Change	-48.66 %	-33.81 %	-20.54 %	27.53 %	195.47 %
Net Income (TTM) in million	1	1	1	1	1
Return On Assets (TTM)	7.09 %	9.5 %	10.48 %	11.21 %	11.08 %
PFHO's Total Ranking	# 544	# 534	# 791	# 1002	# 900
Total Assets (TTM) in million	14	14	14	13	13
Seq. Total Assets Change	2.15 %	2.01 %	3.05 %	-0.16 %	5.2 %
Seq. Net Income Change	68.82 %	-17.57 %	5.38 %	-64.99 %	117.62 %

PFHO's 5 Years Annual ROA >> Back to PFHO Management Effectiveness >> Compare PFHO ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 11
Sector	# 114
Overall	# 855

Return On Assets Statistics
High	Average	Low
43.45 %	13.61 %	-30.15 %
(Dec 31 2014)		(Dec 31 2013)

Financial Statements
Pacific Health Care Organization Inc's Assets	$ 14 million	PFHO's Balance sheet
Pacific Health Care Organization Inc's Income	$ 0 million	Quarterly PFHO's Income Statement
PFHO's Income by Division		See PFHO's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	91.12 %	-34.27 %	56.93 %	6.35 %	2.03 %
Total Assets in million	24	12	19	12	11
Y / Y Net Income Change	57.04 %	14.83 %	56.12 %	-50.46 %	81.05 %
Net Income in million	1	1	1	0	1
Annual Return On Assets	5.84 %	7.11 %	4.07 %	4.09 %	8.78 %

PFHO's 5 Years Annual ROA >> Back to PFHO Management Effectiveness >> Compare PFHO ROA to its Competitors

Comment on PFHO's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA deteriorated to 5.84 %, despite annual net income growth of 57.04 % to $1.39 million, from $0.88 million a year ago, as PFHO's assets increase to $23.76 million, by 57.04 %.

More Return On Assets Ratios
PFHO's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PFHO's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PFHO's Competitors
Subscribers only: Roa for Pacific Health Care Organization Inc's Suppliers
Subscribers only: Return On Assets for PFHO's Customers

You may also want to know
PFHO's Roi	PFHO's Inventory Turnover Ratio	PFHO's Growth Rates	PFHO's Dividend Comparisons
	PFHO's Profitability Ratios	PFHO's Asset Turnover Ratio	PFHO's Dividend Growth
PFHO's Roe	PFHO's Valuation Ratios	PFHO's Financial Strength Ratios	PFHO's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %
Dexcom Inc	14.87 %
Neurocrine Biosciences Inc	14.73 %
Entera Bio Ltd	14.60 %
Standard Biotools Inc	14.31 %
Arcutis Biotherapeutics Inc	14.23 %
Harmony Biosciences Holdings inc	14.15 %
Biolife Solutions Inc	14.09 %
Aveanna Healthcare Holdings Inc	13.82 %
West Pharmaceutical Services Inc	13.64 %
Medinotec Inc	13.38 %
Puma Biotechnology Inc	13.28 %
Sbc Medical Group Holdings Incorporated	13.26 %
Alpha Pro Tech Ltd	13.17 %
Illumina Inc	12.68 %
Spero Therapeutics Inc	12.57 %
Transmedics Group Inc	12.50 %
Eton Pharmaceuticals Inc	12.37 %
Nephros Inc	12.30 %

Date modified: 2026-08-31T11:54:26+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.